Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04667013 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

StatusNot Yet Recruiting
PhasePhase 1
Started2028-09-01
View on ClinicalTrials.gov ↗
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (i.e. how study drug is taken up by the body) of TBN in healthy participants.

Amendment history 2 changes detected by DataLookout

2026-09-12
Primary completion pushed: 2026-03-31 → 2029-03-31
2026-09-12
Completion pushed: 2026-08-30 → 2029-08-30
Trial Details
NCT Number NCT04667013
Lead Sponsor Guangzhou Magpie Pharmaceuticals Co., Ltd.
Conditions Healthy
Enrollment 16 participants
Start Date 2028-09-01
Primary Completion 2029-03-31 (estimated)
Study Completion 2029-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-11